Correlation Between Fulcrum Therapeutics and LandBridge Company

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Fulcrum Therapeutics and LandBridge Company at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Fulcrum Therapeutics and LandBridge Company into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Fulcrum Therapeutics and LandBridge Company LLC, you can compare the effects of market volatilities on Fulcrum Therapeutics and LandBridge Company and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Fulcrum Therapeutics with a short position of LandBridge Company. Check out your portfolio center. Please also check ongoing floating volatility patterns of Fulcrum Therapeutics and LandBridge Company.

Diversification Opportunities for Fulcrum Therapeutics and LandBridge Company

-0.22
  Correlation Coefficient

Very good diversification

The 3 months correlation between Fulcrum and LandBridge is -0.22. Overlapping area represents the amount of risk that can be diversified away by holding Fulcrum Therapeutics and LandBridge Company LLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on LandBridge Company and Fulcrum Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Fulcrum Therapeutics are associated (or correlated) with LandBridge Company. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of LandBridge Company has no effect on the direction of Fulcrum Therapeutics i.e., Fulcrum Therapeutics and LandBridge Company go up and down completely randomly.

Pair Corralation between Fulcrum Therapeutics and LandBridge Company

Given the investment horizon of 90 days Fulcrum Therapeutics is expected to under-perform the LandBridge Company. But the stock apears to be less risky and, when comparing its historical volatility, Fulcrum Therapeutics is 1.41 times less risky than LandBridge Company. The stock trades about -0.16 of its potential returns per unit of risk. The LandBridge Company LLC is currently generating about 0.12 of returns per unit of risk over similar time horizon. If you would invest  5,843  in LandBridge Company LLC on December 22, 2024 and sell it today you would earn a total of  1,862  from holding LandBridge Company LLC or generate 31.87% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Fulcrum Therapeutics  vs.  LandBridge Company LLC

 Performance 
       Timeline  
Fulcrum Therapeutics 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Fulcrum Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's essential indicators remain rather sound which may send shares a bit higher in April 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.
LandBridge Company 

Risk-Adjusted Performance

OK

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in LandBridge Company LLC are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. Despite somewhat unfluctuating fundamental drivers, LandBridge Company sustained solid returns over the last few months and may actually be approaching a breakup point.

Fulcrum Therapeutics and LandBridge Company Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Fulcrum Therapeutics and LandBridge Company

The main advantage of trading using opposite Fulcrum Therapeutics and LandBridge Company positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Fulcrum Therapeutics position performs unexpectedly, LandBridge Company can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in LandBridge Company will offset losses from the drop in LandBridge Company's long position.
The idea behind Fulcrum Therapeutics and LandBridge Company LLC pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.

Other Complementary Tools

Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes